• 266
  • 27
  • Favorite

Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

Reuters2021-08-17

Aug 16 (Reuters) - Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co.

In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.

It also shed a $411 million stake in paint maker Axalta Coating Systems Ltd, a Berkshire holding since 2015.

The changes were disclosed in a regulatory filing detailing Berkshire's U.S.-listed holdings as of June 30.

Berkshire has been a net seller of stocks in 2021, including in the second quarter when it sold $1.1 billion more stocks than it bought.

That suggests Buffett and his investment managers Todd Combs and Ted Weschler remain wary of valuations as stock prices regularly set new highs.

The Standard & Poor's has doubled from its March 2020 trough early in the COVID-19 pandemic.

Berkshire has instead bought back about $14.3 billion of its own stock between January and late July though its share price also set records, and now sits just 2% below its May 7 peak.

The Omaha, Nebraska-based conglomerate ended June with $144.1 billion of cash and equivalents. Berkshire also owns dozens of businesses including the BNSF railroad, Geico auto insurance and Dairy Queen ice cream.

Organon specializes in contraception and other women's health products, and has dozens of brands in other fields.

Berkshire reported a $46.9 million Organon stake as of June 30.

Its largest investments on that date were $124.3 billion in Apple Inc and $42.6 billion in $Bank of America Corp(BAC-N)$.

In Monday's filing, Berkshire also reported lowered stakes in Chevron Corp, General Motors Co, media company Liberty Global Plc, insurance broker Marsh & McLennan Cos and US Bancorp.

It reported increased stakes in supermarket chain Kroger Co, home furnishings chain RH and Marsh rival Aon Plc, which under regulatory pressure called off a $30 billion merger with Willis Towers Watson Plc last month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment27

  • Portfolio50
    ·2021-08-17
    Net seller of stocks and that much cash - not a good sign! Gonna be taking money off the table too (once target profits are hit).
    Reply
    Report
  • bernardtayet
    ·2021-08-17
    Good to follow up 
    Reply
    Report
  • sickeninglim
    ·2021-08-17
    Wow......
    Reply
    Report
  • HENRYCSC
    ·2021-08-17
    Ok
    Reply
    Report
  • RIC
    ·2021-08-17
    good 
    Reply
    Report
  • KYHBKO
    ·2021-08-17
    some regard such moves as defensive ... sitting on over $144 Billion worth of cash ... to swoop in when the prices turned into fair value in anticipation of market correction or more. happy investing all. 
    Reply
    Report
  • ToongMH
    ·2021-08-17
    Good to read
    Reply
    Report
  • Ahlec
    ·2021-08-17
    Like
    Reply
    Report
  • 冰眼
    ·2021-08-17
    Pls like 
    Reply
    Report
  • Chris68
    ·2021-08-17
    Good to know 
    Reply
    Report
    Fold Replies
    • dt1
      [微笑]
      2021-08-17
      Reply
      Report
  • June陈
    ·2021-08-17
    Like.
    Reply
    Report
    Fold Replies
    • Jackosen
      done
      2021-08-17
      Reply
      Report
  • 股神不是神
    ·2021-08-17
    Berkshire’s top 10 holdings stayed relatively unchanged in the last quarter. Here’s what they are:
    Reply
    Report
    Fold Replies
    • Michael8208
      [Great]
      2021-12-09
      Reply
      Report
    • KW1
      ok
      2021-09-11
      Reply
      Report
    • Chris68
      Good info
      2021-08-17
      Reply
      Report
  • Blading23
    ·2021-08-17
    Read
    Reply
    Report
    Fold Replies
    • Blading23
      comment
      2021-08-17
      Reply
      Report
  • Targarean
    ·2021-08-17
    Pharma is getting over-valued now with all the focus on vaccine
    Reply
    Report
  • popcorntan
    ·2021-08-17
    Nice
    Reply
    Report
  • Lanying
    ·2021-08-17
    O
    Reply
    Report
    Fold Replies
    • Lanying
      O
      2021-08-17
      Reply
      Report
  • mQ
    ·2021-08-17
    Yeah
    Reply
    Report
  • Rashamon96
    ·2021-08-17
    I think better observe the market for a while. 
    Reply
    Report
    Fold Replies
    • gupzbajaj
      for sure
      2021-08-17
      Reply
      Report
    • mQ
      ??
      2021-08-17
      Reply
      Report
  • LIAN230221
    ·2021-08-17
    Please like this and comment thanks 
    Reply
    Report
    Fold Replies
    • 1Robo
      ok
      2021-08-17
      Reply
      Report
  • CMF1979
    ·2021-08-17
    When prices are hitting records every now and then.. and everyone is rushing to buy.. it is always a little scary.. ??
    Reply
    Report
    Fold Replies
    • WCS1981
      Ya like rIding the rollercoaster in the dark[Sweats]
      2021-08-17
      Reply
      Report
    • Phyusin
      Yeah
      2021-08-17
      Reply
      Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial